CAS 1432500-66-7

Fórmula: C26H26N2O5

InChI: InChI=1S/C26H26N2O5/c29-23(20-11-5-6-12-21(20)26(32)33)27-14-13-16-7-1-2-8-17(16)22(27)15-28-24(30)18-9-3-4-10-19(18)25(28)31/h1-4,7-10,20-22H,5-6,11-15H2,(H,32,33)/t20-,21+,22-/m1/s1

Clave InChI: LNENLABLFGGAFF-BHIFYINESA-N

SMILES: C1CC[C@@H]([C@@H](C1)C(=O)N2CCC3=CC=CC=C3[C@H]2CN4C(=O)C5=CC=CC=C5C4=O)C(=O)O

ML334

CAS: 1432500-66-7

ML334

Fórmula: C₂₆H₂₆N₂O₅

Pureza: ≥98%

Forma y color: Solid

Peso molecular: 446.49

Ref: 54-BUP21839

ML 334

CAS: 1432500-66-7

Pureza: 99.76%

Ref: IN-DA01ENLC

ML334

CAS: 1432500-66-7

ML334 (LH601A) is an NRF2 activator that inhibits cardiac fibroblast activation and proliferation ameliorating myocardial infarction-induced cardiac fibrosis.

Fórmula: C₂₆H₂₆N₂O₅

Pureza: 98.06% - 98.06%

Forma y color: Solid

Peso molecular: 446.49

Ref: TM-T12078

ML334

CAS: 1432500-66-7

(1S,2R)-2-((S)-1-((1,3-Dioxoisoindolin-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)cyclohexane-1-carboxylic acid

Fórmula: C₂₆H₂₆N₂O₅

Pureza: 98%

Peso molecular: 446.5

Ref: IN-DG01300994

ML 334

CAS: 1432500-66-7

ML 334 is a drug that has been developed to treat cancer. It is an inhibitor of the enzyme 18-alpha-glycyrrhetinic acid, which is found in human liver and may play a role in cancer development. ML334 also inhibits the protein–protein interaction between two proteins, one of which is a target gene for cancer cells. This inhibition leads to reduced expression of pro-inflammatory cytokines and improved energy production in hypoxic tumor cells, which are resistant to chemotherapy. ML334 also has detoxification properties due to its ability to inhibit detoxification enzymes such as CYP1A1 and CYP2E1, which may alter the metabolism of various drugs, including insulin.

Fórmula: C₂₆H₂₆N₂O₅

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 446.5 g/mol

Ref: 3D-HHC50066

ML 334

Producto controlado

CAS: 1432500-66-7

Fórmula: C₂₆H₂₆N₂O₅

Forma y color: Neat

Peso molecular: 446.495

Ref: TR-M425438